T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$8.01B |
| 2 |
Amazon
AMZN
|
+$5.64B |
| 3 |
Danaher
DHR
|
+$4.2B |
| 4 |
Gilead Sciences
GILD
|
+$4.09B |
| 5 |
JPMorgan Chase
JPM
|
+$4.03B |
Top Sells
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 14.17% |
| 2 | Healthcare | 13.97% |
| 3 | Consumer Discretionary | 13.35% |
| 4 | Industrials | 11.58% |
| 5 | Technology | 10.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
551
Acadia Healthcare
ACHC
$2.82B
| $107M | 0.03% |
+3,239,950
| New | +$105M |
|
|
HR
552
DELISTED
Healthcare Realty Trust Incorporated
HR
| $107M | 0.03% |
+4,187,817
| New | +$117M |
|
553
Devon Energy
DVN
$48.8B
| $106M | 0.03% |
+2,052,131
| New | +$114M |
|
554
Intuitive Surgical
ISRG
$142B
| $106M | 0.03% |
+1,887,237
| New | +$104M |
|
555
Acadia Realty Trust
AKR
$2.86B
| $106M | 0.03% |
+4,299,730
| New | +$117M |
|
556
Capri Holdings
CPRI
$1.77B
| $106M | 0.03% |
+1,707,645
| New | +$100M |
|
557
A.O. Smith
AOS
$8.5B
| $106M | 0.03% |
+5,830,660
| New | +$109M |
|
558
Mercado Libre
MELI
$92.6B
| $106M | 0.03% |
+980,590
| New | +$106M |
|
559
Zillow
ZG
$8.15B
| $105M | 0.03% |
+5,612,520
| New | +$104M |
|
560
Neurocrine Biosciences
NBIX
$15.3B
| $105M | 0.03% |
+7,868,859
| New | +$96.7M |
|
561
McGrath RentCorp
MGRC
$2.94B
| $105M | 0.03% |
+3,069,050
| New | +$97.2M |
|
562
Ionis Pharmaceuticals
IONS
$9.28B
| $103M | 0.03% |
+3,835,755
| New | +$81.6M |
|
|
PSB
563
DELISTED
PS Business Parks, Inc.
PSB
| $102M | 0.03% |
+1,411,999
| New | +$110M |
|
564
Belden
BDC
$5.36B
| $102M | 0.03% |
+2,040,373
| New | +$104M |
|
565
Aon
AON
$75.8B
| $101M | 0.03% |
+1,574,680
| New | +$99.8M |
|
566
HEICO Corp Class A
HEI.A
$38.1B
| $101M | 0.03% |
+8,364,642
| New | +$97.8M |
|
567
PPG Industries
PPG
$25.5B
| $101M | 0.03% |
+1,381,564
| New | +$102M |
|
568
Zions Bancorporation
ZION
$10.5B
| $101M | 0.03% |
+3,488,971
| New | +$91.2M |
|
|
LHO
569
DELISTED
LaSalle Hotel Properties
LHO
| $101M | 0.03% |
+4,078,990
| New | +$105M |
|
|
AVNR
570
DELISTED
AVANIR PHARMACEUTICALS, INC CL A
AVNR
| $99.9M | 0.03% |
+21,722,711
| New | +$74.7M |
|
571
Woodward
WWD
$21.2B
| $99.8M | 0.03% |
+2,495,950
| New | +$94.4M |
|
572
American International
AIG
$39.8B
| $99.8M | 0.03% |
+2,232,424
| New | +$95.8M |
|
|
EMC
573
DELISTED
EMC CORPORATION
EMC
| $99.8M | 0.03% |
+4,224,483
| New | +$99.6M |
|
574
Jack in the Box
JACK
$358M
| $99.7M | 0.03% |
+2,536,900
| New | +$93M |
|
575
Silicon Laboratories
SLAB
$7.29B
| $99.1M | 0.03% |
+2,394,250
| New | +$98.8M |
|
Similar funds
T. Rowe Price Associates's Q2 2013 Portfolio in Review
Q2 2013 is the first quarter with a 13F filing on record for T. Rowe Price Associates, which disclosed 2,429 positions worth $374B. Its ten largest holdings account for 12% of the portfolio.
Its largest position is Alphabet (Google) Class C: 378,851,526 shares worth $8.31B.
By sector, the portfolio is most concentrated in Financials at 14% of assets, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q2 2013 buy was Alphabet (Google) Class C: 378,851,526 shares worth $8.31B.
- T. Rowe Price Associates's ten largest holdings make up 12% of its $374B portfolio in Q2 2013.
- T. Rowe Price Associates disclosed 2,429 positions in Q2 2013, its first 13F filing on record.
Based on T. Rowe Price Associates's 13F filing for Q2 2013, filed 14 Aug 2013.